Lpath lpath.com


Public list: BIO 2016 (619) Pharma Startups (4733)

Lpath (NASDAQ: LPTN) discovers and develops therapeutic antibodies that bind and inhibit bioactive lipids that contribute to disease.

Lpath (NASDAQ: LPTN) discovers and develops therapeutic antibodies that bind and inhibit bioactive lipids that contribute to disease.

Company (IPO / Went public)

Phone: 858-678-0800

Fax:

4025 Sorrento Valley Blvd

San Diego, 92121
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Lpath $7.2M Aug 8, 2008

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Lpath Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 8 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Prevention and treatment of pain using antibodies to lysophosphatidic acid Jul 14, 2011 Mar 01, 2016 Patent
Methods and reagents for detecting bioactive lipids May 30, 2007 Mar 01, 2016 Patent
Immune-derived moieties reactive against lysophosphatidic acid May 30, 2007 Dec 22, 2015 Patent
Pharmaceutical compositions for binding sphingosine-1-phosphate Apr 05, 2009 Nov 10, 2015 Patent
Compositions and methods for binding lysophosphatidic acid Mar 18, 2009 Oct 20, 2015 Patent
See all 32 patents